Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PATHOLOGICAL STAGE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 326 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. D'Amico, AV
      Perineural invasion as a predictor of PSA outcome following local therapy for patients with clinically localized prostate cancer

      CANCER JOURNAL
    2. Koh, WJ; Tran, AB; Douglas, JG; Stelzer, KJ
      Radiation therapy in endometrial cancer

      BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY
    3. Van der Cruijsen-Koeter, IW; Wildhagen, MF; De Koning, HJ; Schroder, FH
      The value of current diagnostic tests in prostate cancer screening

      BJU INTERNATIONAL
    4. Goddard, JC; Sutton, CD; Berry, DP; O'Byrne, KJ; Kockelbergh, RC
      The use of microvessel density in assessing human urological tumours

      BJU INTERNATIONAL
    5. Wilkinson, BA; Hamdy, FC
      State-of-the-art staging in prostate cancer

      BJU INTERNATIONAL
    6. Migita, T; Oda, Y; Naito, S; Morikawa, W; Kuwano, M; Tsuneyoshi, M
      The accumulation of angiostatin-like fragments in human prostate carcinoma

      CLINICAL CANCER RESEARCH
    7. Mehta, R; Kyshtoobayeva, A; Kurosaki, T; Small, EJ; Kim, H; Stroup, R; McLaren, CE; Li, KT; Fruehauf, JP
      Independent association of angiogenesis index with outcome in prostate cancer

      CLINICAL CANCER RESEARCH
    8. Alexandre, J; Fizazi, K; Mahe, C; Culine, S; Droz, JP; Theodore, C; Terrier-Lacombe, MJ
      Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapse

      EUROPEAN JOURNAL OF CANCER
    9. Schroder, FH
      Prostate cancer: natural history and surgical treatment of localised disease

      EUROPEAN JOURNAL OF CANCER
    10. Egawa, S; Suyama, K; Arai, Y; Tsukayama, C; Matsumoto, K; Kuwao, S; Baba, S
      Treatment outcome by risk group after radical prostatectomy in Japanese men

      INTERNATIONAL JOURNAL OF UROLOGY
    11. El-Gabry, EA; Halpern, EJ; Strup, SE; Gomella, LG
      Imaging prostate cancer: Current and future applications

      ONCOLOGY-NEW YORK
    12. Brasso, K; Iversen, P
      The clinical utility of prostate specific antigen

      JOURNAL OF TUMOR MARKER ONCOLOGY
    13. Shariat, SF; Shalev, M; Menesses-Diaz, A; Kim, IY; Kattan, MW; Wheeler, TM; Slawin, KM
      Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy

      JOURNAL OF CLINICAL ONCOLOGY
    14. Albers, P; Perabo, FGE; Melchior, D; Siener, R
      Adjuvant chemotherapy in stage I and stage II testicular cancer

      WORLD JOURNAL OF UROLOGY
    15. Egawa, S; Suyama, K; Arai, Y; Matsumoto, K; Tsukayama, C; Kuwao, S; Baba, S
      A study of pretreatment nomograms to predict pathological stage and biochemical recurrence after radical prostatectomy for clinically resectable prostate cancer in Japanese men

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    16. Thornbury, JR; Ornstein, DK; Choyke, PL; Langlotz, CP; Weinreb, JC
      Prostate Cancer: What is the future role for imaging?

      AMERICAN JOURNAL OF ROENTGENOLOGY
    17. Creutzberg, CL; van Putten, WLJ; Koper, PC; Lybeert, MLM; Jobsen, JJ; Warlam-Rodenhuis, CC; De Winter, KAJ; Lutgens, LCHW; van den Bergh, ACM; van der Steen-Banasik, E; Beerman, H; van Lent, M
      The morbidity of treatment for patients with stage I endometrial cancer: Results from a randomized trial

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    18. Touboul, E; Belkacemi, Y; Buffat, L; Deniaud-Alexandre, E; Lefranc, JP; Lhuillier, P; Uzan, S; Jannet, D; Uzan, M; Antoine, M; Huart, J; Ganansia, V; Milliez, J; Blondon, J; Housset, M; Schlienger, M
      Adenocarcinoma of the endometrium treated with combined irradiation and surgery: Study of 437 patients

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    19. Hamdy, FC
      Prognostic and predictive factors in prostate cancer

      CANCER TREATMENT REVIEWS
    20. Sedelaar, JPM; van Leenders, GJLH; Hulsbergen-van de Kaa, CA; van der Poel, HG; van der Laak, JAWM; Debruyne, FMJ; Wijkstra, H; de la Rosette, JJMCH
      Microvessel density: Correlation between contrast ultrasonography and histology of prostate cancer

      EUROPEAN UROLOGY
    21. Engelbrecht, MR; Jager, GJ; Severens, JL
      Patient selection for magnetic resonance imaging of prostate cancer

      EUROPEAN UROLOGY
    22. Padilla, J; Penalver, JC; Calvo, V; Zarza, AG; Pastor, J; Blasco, E; Paris, F
      Model for risk of mortality in stage I non-small cell bronchogenic carcinoma

      ARCHIVOS DE BRONCONEUMOLOGIA
    23. Moskalik, AP; Rubin, MA; Wojno, KJ; Bree, R; Rubin, JM; Fowlkes, JB; Montie, JE; Manley, S; Carson, PL
      Analysis of three-dimensional Doppler ultrasonographic quantitative measures for the discrimination of prostate cancer

      JOURNAL OF ULTRASOUND IN MEDICINE
    24. Shekarriz, B; Upadhyay, J; Bianco, FJ; Tefilli, MV; Tiguert, R; Gheiler, EL; Grignon, DJ; Pontes, JE; Wood, DP
      Impact of preoperative serum PSA level from 0 to 10 ng/ml on pathological findings and disease-free survival after radical prostatectomy

      PROSTATE
    25. Strohmeyer, D; Frauscher, F; Klauser, A; Recheis, W; Rogatsch, H; Eibl, G; Horninger, W; Steiner, H; Volgger, H; Bartsch, G
      Contrast-enhanced Transrectal Color Doppler Ultrasonography (TRCDUS) for assessment of angiogenesis in prostate cancer

      ANTICANCER RESEARCH
    26. Furuya, Y; Ohta, S; Sato, N; Kotake, T; Sugano, I; Nagao, K; Masai, M
      Prostate-specific antigen density adjusted for the transition zone for staging clinically localized prostate cancer in Japanese patients with intermediate serum prostate-specific antigen levels

      ANTICANCER RESEARCH
    27. Ichinose, Y; Kato, H; Koike, T; Tsuchiya, R; Fujisawa, T; Shimizu, N; Watanabe, Y; Mitsudomi, T; Yoshimura, M
      Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the JapanClinical Oncology Group to plan for clinical trials

      LUNG CANCER
    28. Moul, JW; Kane, CJ; Malkowicz, SB
      The role of imaging studies and molecular markers for selecting candidatesfor radical prostatectomy

      UROLOGIC CLINICS OF NORTH AMERICA
    29. Link, RE; Morton, RA
      Indications for pelvic lymphadenectomy in prostate cancer

      UROLOGIC CLINICS OF NORTH AMERICA
    30. Sokoloff, MH; Brendler, CB
      Indications and contraindications for nerve-sparing radical prostatectomy

      UROLOGIC CLINICS OF NORTH AMERICA
    31. Figg, WD; Arlen, P; Gulley, J; Fernandez, P; Noone, M; Fedenko, K; Hamilton, M; Parker, C; Kruger, EA; Pluda, J; Dahut, WL
      A randomized phase II trial of docetaxel (taxotere) plus thalidomide in androgen-independent prostate cancer

      SEMINARS IN ONCOLOGY
    32. Chay, C; Smith, DC
      Adjuvant and neoadjuvant therapy in prostate cancer

      SEMINARS IN ONCOLOGY
    33. Soulie, M; Aziza, R; Escourrou, G; Seguin, P; Tollon, C; Molinier, L; Bachaud, JM; Joffre, F; Plante, P
      Assessment of the risk of positive surgical margins with pelvic phased-array magnetic resonance imaging in patients with clinically localized prostate cancer: A prospective study

      UROLOGY
    34. Okegawa, T; Kato, M; Nutahara, K; Higashihara, E
      Prognostic value of three molecular forms of prostate-specific antigen ratios in patients with prostate adenocarcinoma

      UROLOGY
    35. Han, M; Piantadosi, S; Zahurak, ML; Sokoll, LJ; Chan, DW; Epstein, JI; Walsh, PC; Partin, AW
      Serum acid phosphatase level and biochemical recurrence following radical prostatectomy for men with clinically localized prostate cancer

      UROLOGY
    36. Batuello, JT; Gamito, EJ; Crawford, ED; Han, M; Partin, AW; McLeod, DG; O'Donnell, C
      Artificial neural network model for the assessment of lymph node spread inpatients with clinically localized prostate cancer

      UROLOGY
    37. Cheung, R; Altschuler, MD; D'Amico, AV; Malkowicz, SB; Wein, AJ; Whittington, R
      ROC optimization may improve risk stratification of prostate cancer patients

      UROLOGY
    38. Okada, K; Yokoyama, K; Okihara, K; Ukimura, O; Kojima, M; Miki, T; Takamatsu, T
      Immunohistochemical localization of platelet-derived endothelial cell growth factor expression and its relation to angiogenesis in prostate

      UROLOGY
    39. Gregori, A; Vieweg, J; Dahm, P; Paulson, DF
      Comparison of ultrasound-guided biopsies and prostatectomy specimens: Predictive accuracy of Gleason score and tumor site

      UROLOGIA INTERNATIONALIS
    40. Walsh, PC
      Re: High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized cancer

      JOURNAL OF UROLOGY
    41. Moul, JW; Connelly, RR; Lubeck, DP; Bauer, JJ; Sun, L; Flanders, SC; Grossfeld, GD; Carroll, PR
      Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the center for prostate disease research and cancer of the prostate strategic urologic research endeavor databases

      JOURNAL OF UROLOGY
    42. Han, M; Partin, AW; Piantadosi, S; Epstein, JI; Walsh, PC
      Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer

      JOURNAL OF UROLOGY
    43. Ross, PL; Scardino, PT; Kattan, MW
      Catalog of prostate cancer nomograms

      JOURNAL OF UROLOGY
    44. Grossfeld, GD; Chang, JJ; Broering, JM; Li, JP; Lubeck, DP; Flanders, SC; Carroll, PR
      Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor database

      JOURNAL OF UROLOGY
    45. Graefen, M; Haese, A; Pichlmeier, U; Hammerer, PG; Noldus, J; Butz, K; Erbersdobler, A; Henke, RP; Michl, U; Fernandez, S; Huland, H
      A validated strategy for side specific prediction of organ confined prostate cancer: A tool to select for nerve sparing radical prostatectomy

      JOURNAL OF UROLOGY
    46. Blute, ML; Bergstralh, EJ; Iocca, A; Scherer, B; Zincke, H
      Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy

      JOURNAL OF UROLOGY
    47. D'Amico, AV; Wu, YH; Chen, MH; Nash, M; Renshaw, AA; Richie, JP
      Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer

      JOURNAL OF UROLOGY
    48. Campbell, T; Blasko, J; Crawford, ED; Forman, J; Hanks, G; Kuban, D; Montie, J; Moul, J; Pollack, A; Raghavan, D; Ray, P; Roach, M; Steinberg, G; Stone, N; Thompson, I; Vogelzang, N; Vijayakumar, S
      Clinical staging of prostate cancer: Reproducibility and clarification of issues

      INTERNATIONAL JOURNAL OF CANCER
    49. Maniwa, Y; Yoshimura, M; Obayashi, C; Inaba, M; Kiyooka, K; Kanki, M; Okita, Y
      Association of p53 gene mutation and telomerase activity in resectable non-small cell lung cancer

      CHEST
    50. Sebo, TJ; Cheville, JC; Riehle, DL; Lohse, CM; Pankratz, VS; Myers, RP; Blute, ML; Zincke, H
      Predicting prostate carcinoma volume and stage at radical prostatectomy byassessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen - A report of 454 cases

      CANCER
    51. Ward, AM; Catto, JWF; Hamdy, FC
      Prostate specific antigen: biology, biochemistry and available commercial assays

      ANNALS OF CLINICAL BIOCHEMISTRY
    52. Fischer, CG; Altwein, JE; Luboldt, HJ
      Prognostic factors in prostate cancer

      AKTUELLE UROLOGIE
    53. Schulman, CC; Altwein, JE; Zlotta, AR
      Treatment options after failure of local curative treatments in prostate cancer: a controversial issue

      BJU INTERNATIONAL
    54. Unal, D; Sedelaar, JPM; Aarnink, RG; Van Leenders, GJLH; Wijkstra, H; Debruyne, FMJ; De La Rosette, JJMCH
      Three-dimensional contrast-enhanced power Doppler ultrasonography and conventional examination methods: the value of diagnostic predictors of prostate cancer

      BJU INTERNATIONAL
    55. Jones, A; Fujiyama, C; Turner, K; Fuggle, S; Cranston, D; Bicknell, R; Harris, AL
      Elevated serum vascular endothelial growth factor in patients with hormone-escaped prostate cancer

      BJU INTERNATIONAL
    56. Pentyala, SN; Lee, J; Hsieh, K; Waltzer, WC; Trocchia, A; Musacchia, L; Rebecchi, MJ; Khan, SA
      Prostate cancer: a comprehensive review

      MEDICAL ONCOLOGY
    57. Haseman, MK; Rosenthal, SA; Polascik, TJ
      Capromab pendetide imaging of prostate cancer

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    58. Bernstein, MR; Cangiano, T; D'Amico, A; Chittams, J; Hardy, C; Whittington, RD; Tomaszewski, JE; Schnall, MD; Wein, AJ; Malkowicz, SB
      Endorectal coil magnetic resonance imaging and clinicopathologic findings in T1c adenocarcinoma of the prostate

      UROLOGIC ONCOLOGY
    59. Stephan, C; Jung, K; Lein, M; Sinha, P; Schnorr, D; Loening, SA
      Molecular forms of prostate-specific antigen and human kallikrein 2 as promising tools for early diagnosis of prostate cancer

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    60. Jin, RJ; Kwak, C; Lee, SG; Lee, CH; Soo, CG; Park, MS; Lee, E; Lee, SE
      The application of an anti-angiogenic gene (thrombospondin-1) in the treatment of human prostate cancer xenografts

      CANCER GENE THERAPY
    61. Kakehi, Y; Kamoto, T; Okuno, H; Terai, A; Terachi, T; Ogawa, O
      Per-operative frozen section examination of pelvic nodes is unnecessary for the majority of clinically localized prostate cancers in the prostate-specific antigen era

      INTERNATIONAL JOURNAL OF UROLOGY
    62. Garcia, FU; Taylor, CA; Hou, JS; Rukstalis, DB; Stearns, ME
      Increased cellularity of tumor-encased native vessels in prostate carcinoma is a marker for tumor progression

      MODERN PATHOLOGY
    63. Datta, MW; Renshaw, AA; Dutta, A; Hoffman, MA; Loughlin, KR
      Evaluation of cyclin expression in testicular germ cell tumors: Cyclin E correlates with tumor type, advanced clinical stage, and pulmonary metastasis

      MODERN PATHOLOGY
    64. Russo, P
      Salvage radical prostatectomy after radiation therapy and brachytherapy

      JOURNAL OF ENDOUROLOGY
    65. Daliani, D
      Development of angiogenesis inhibition as therapy for prostate cancer

      ONCOLOGY-NEW YORK
    66. D'Amico, AV; Whittington, R; Malkowicz, SB; Schultz, D; Fondurulia, J; Chen, MH; Tomaszewski, JE; Renshaw, AA; Wein, A; Richie, JP
      Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer

      JOURNAL OF CLINICAL ONCOLOGY
    67. Pettaway, CA; Pisters, LL; Troncoso, P; Slaton, J; Finn, L; Kamoi, K; Logothetis, CJ
      Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: Feasibility and preliminary results

      JOURNAL OF CLINICAL ONCOLOGY
    68. Kattan, MW; Zelefsky, MJ; Kupelian, PA; Scardino, PT; Fuks, Z; Leibel, SA
      Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer

      JOURNAL OF CLINICAL ONCOLOGY
    69. Cheng, L; Slezak, J; Bergstralh, EJ; Myers, RP; Zincke, H; Bostwick, DG
      Preoperative prediction of surgical margin status in patients with prostate cancer treated by radical prostatectomy

      JOURNAL OF CLINICAL ONCOLOGY
    70. Reckwitz, T; Potter, SR; Partin, AW
      Prediction of locoregional extension and metastatic disease in prostate cancer: a review

      WORLD JOURNAL OF UROLOGY
    71. Zlotta, AR; Schulman, CC
      Neoadjuvant and adjuvant hormone therapy for prostate cancer

      WORLD JOURNAL OF UROLOGY
    72. Schroder, FH; van den Ouden, D
      Management of locally advanced prostate cancer - 2. Radiotherapy, neoadjuvant endocrine treatment, update 1997-1999

      WORLD JOURNAL OF UROLOGY
    73. de la Taille, A; Rubin, MA; Buttyan, R; Olsson, CA; Bagiella, E; Burchardt, M; Wellisch, OM; Katz, AE
      Is microvascular invasion on radical prostatectomy specimens a useful predictor of PSA recurrence for prostate cancer patients?

      EUROPEAN UROLOGY
    74. Ravery, V; Chastang, C; Toublanc, M; Boccon-Gibod, L; Delmas, V; Boccon-Gibod, L
      Percentage of cancer on biopsy cores accurately predicts extracapsular extension and biochemical relapse after radical prostatectomy for T1-T2 prostate cancer

      EUROPEAN UROLOGY
    75. Malavaud, B; Villers, A; Ravery, V; Tollon, C; Rischmann, P; Charlet, JP; Plante, P; Boccon-Gibod, L; Sarramon, JP
      Role of preoperative positive apical biopsies in the prediction of specimen-confined prostate cancer after radical retropubic prostatectomy: A multi-institutional study

      EUROPEAN UROLOGY
    76. Strohmeyer, D; Rossing, C; Bauerfeind, A; Kaufmann, O; Schlechte, H; Bartsch, G; Loening, S
      Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer

      PROSTATE
    77. Strohmeyer, D; Rossing, C; Strauss, F; Bauerfeind, A; Kaufmann, O; Loening, S
      Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer

      PROSTATE
    78. Wurmbach, JH; Hammerer, P; Sevinc, S; Huland, H; Ergun, S
      The expression of angiopoietins and their receptor Tie-2 in human prostatecarcinoma

      ANTICANCER RESEARCH
    79. Halvorsen, OJ; Haukaas, S; Hoisaeter, PA; Akslen, LA
      Independent prognostic importance of microvessel density in clinically localized prostate cancer

      ANTICANCER RESEARCH
    80. Ash, D; Flynn, A; Battermann, J; de Reijke, T; Lavagnini, P; Blank, L
      ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer

      RADIOTHERAPY AND ONCOLOGY
    81. Rubin, MA; Dunn, R; Kambham, N; Misick, CP; O'Toole, KM
      Should a Gleason score be assigned to a minute focus of carcinoma on prostate biopsy?

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    82. Olumi, AF; Richie, JP; Schultz, DJ; D'Amico, AV
      Calculated volume of prostate cancer identifies patients with clinical stage T1c disease at high risk of biochemical recurrence after radical prostatectomy: A preliminary study

      UROLOGY
    83. Cheng, L; Weaver, AL; Bostwick, DG
      Predicting extravesical extension of bladder carcinoma: A novel method based on micrometer measurement of the depth of invasion in transurethral resection specimens

      UROLOGY
    84. Krupski, T; Petroni, GR; Frierson, HF; Theodorescu, D
      Microvessel density, p53, retinoblastoma, and chromogranin a immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostate

      UROLOGY
    85. D'Amico, AV; Whittington, R; Malkowicz, SB; Wu, YH; Chen, MH; Art, M; Tomaszewski, JE; Wein, A
      Combination of the preoperative PSA level, biopsy Gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in menwith clinically localized prostate cancer

      UROLOGY
    86. Carducci, MA
      Adjuvant chemotherapy for T3 prostate cancer: Not ready for prime time

      UROLOGY
    87. Weidner, N
      Angiogenesis as a predictor of clinical outcome in cancer patients

      HUMAN PATHOLOGY
    88. Jager, GJ; Severens, JL; Thornbury, JR; de la Rosette, JJMCH; Ruijs, SHJ; Barentsz, JO
      Prostate cancer staging: Should MR imaging be used? - A decision analytic approach

      RADIOLOGY
    89. Presti, JC
      Prostate cancer: Assessment of risk using digital rectal, examination, tumor grade, prostate-specific antigen, and systematic biopsy

      RADIOLOGIC CLINICS OF NORTH AMERICA
    90. Yu, KK; Hricak, H
      Imaging prostate cancer

      RADIOLOGIC CLINICS OF NORTH AMERICA
    91. Kurhanewicz, J; Vigneron, DB; Males, RG; Swanson, MG; Yu, KK; Hricak, H
      The prostate: MR imaging and spectroscopy - Present and future

      RADIOLOGIC CLINICS OF NORTH AMERICA
    92. Gao, X; Mohideen, N; Flanigan, RC; Waters, WB; Wojcik, EM; Leman, CR
      The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: Implications for treatment selection

      JOURNAL OF UROLOGY
    93. Vis, AN; Noordzij, MA; Fitoz, K; Wildhagen, MF; Schroder, FH; van der Kwast, TH
      Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer

      JOURNAL OF UROLOGY
    94. Hermans, BP; Sweeney, CJ; Foster, RS; Einhorn, LE; Donohue, JP
      Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection

      JOURNAL OF UROLOGY
    95. Leibovich, BC; Cheng, L; Weaver, AL; Myers, RP; Bostwick, DG
      Outcome prediction with p53 immunostaining after radical prostatectomy in patients with locally advanced prostate cancer

      JOURNAL OF UROLOGY
    96. Stamey, TA; Yemoto, CM; McNeal, JE; Sigal, BM; Johnstone, IM
      Prostate cancer is highly predictable: A prognostic equation based on all morphological variables in radical prostatectomy specimens

      JOURNAL OF UROLOGY
    97. Grossfeld, GD; Chang, JJ; Broering, JM; Miller, DP; Yu, J; Flanders, SC; Henning, JM; Stier, DM; Carroll, PR
      Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: Data from the CaPSURE database

      JOURNAL OF UROLOGY
    98. Sebo, TJ; Bock, BJ; Cheville, JC; Lohse, C; Wollan, P; Zincke, H
      The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy

      JOURNAL OF UROLOGY
    99. Peschel, RE; Robnett, TJ; Hesse, D; King, CR; Ennis, RD; Schiff, PB; Wilson, LD
      PSA based review of adjuvant and salvage radiation therapy vs. observationin postoperative prostate cancer patients

      INTERNATIONAL JOURNAL OF CANCER
    100. Latil, A; Bieche, I; Pesche, S; Valeri, A; Fournier, G; Cussenot, O; Lidereau, R
      VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms

      INTERNATIONAL JOURNAL OF CANCER


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/08/20 alle ore 04:01:31